143 related articles for article (PubMed ID: 34894337)
1. Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report.
Beres B; Yusenko M; Peterfi L; Kovacs G; Banyai D
Cell Oncol (Dordr); 2022 Feb; 45(1):193-198. PubMed ID: 34894337
[TBL] [Abstract][Full Text] [Related]
2. M2 Macrophage Marker Chitinase 3-Like 2 (CHI3L2) Associates With Progression of Conventional Renal Cell Carcinoma.
Pusztai C; Yusenko MV; Banyai D; Szanto A; Kovacs G
Anticancer Res; 2019 Dec; 39(12):6939-6943. PubMed ID: 31810965
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic Expression of AXL Is Associated With High Risk of Postoperative Relapse of Conventional Renal Cell Carcinoma.
Peterfi L; Bjercke T; Yusenko MV; Kovacs G; Banyai D
Anticancer Res; 2020 Jun; 40(6):3485-3489. PubMed ID: 32487648
[TBL] [Abstract][Full Text] [Related]
4. Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome.
Zimmermann U; Woenckhaus C; Teller S; Venz S; Langheinrich M; Protzel C; Maile S; Junker H; Giebel J
Histol Histopathol; 2007 May; 22(5):527-34. PubMed ID: 17330807
[TBL] [Abstract][Full Text] [Related]
5. Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma.
Javorhazy A; Farkas N; Beothe T; Pusztai C; Szanto A; Kovacs G
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1947-53. PubMed ID: 27417314
[TBL] [Abstract][Full Text] [Related]
6. Expression of TXNIP is associated with angiogenesis and postoperative relapse of conventional renal cell carcinoma.
Meszaros M; Yusenko M; Domonkos L; Peterfi L; Kovacs G; Banyai D
Sci Rep; 2021 Aug; 11(1):17200. PubMed ID: 34433833
[TBL] [Abstract][Full Text] [Related]
7. FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma.
Peterfi L; Yusenko MV; Kovacs G; Beothe T
Neoplasia; 2023 Jan; 35():100854. PubMed ID: 36516488
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation - report of a unique case.
Petersson F; Michal M; Franco M; Hes O
Int J Clin Exp Pathol; 2010 May; 3(5):534-40. PubMed ID: 20606735
[TBL] [Abstract][Full Text] [Related]
9. A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis.
Li G; Forest F; Feng G; Gentil-Perret A; Péoc'h M; Cottier M; Mottet N
Urol Oncol; 2014 Nov; 32(8):1272-6. PubMed ID: 24996774
[TBL] [Abstract][Full Text] [Related]
10. IgG is involved in the migration and invasion of clear cell renal cell carcinoma.
Sheng Z; Liu Y; Qin C; Liu Z; Yuan Y; Hu F; Du Y; Yin H; Qiu X; Xu T
J Clin Pathol; 2016 Jun; 69(6):497-504. PubMed ID: 26519488
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
[TBL] [Abstract][Full Text] [Related]
12. Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma.
Peterfi L; Banyai D; Yusenko MV; Bjercke T; Kovacs G
Br J Cancer; 2020 Jun; 122(12):1818-1824. PubMed ID: 32307444
[TBL] [Abstract][Full Text] [Related]
13. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.
NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J
Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054
[TBL] [Abstract][Full Text] [Related]
14. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.
Lane BR; Li J; Zhou M; Babineau D; Faber P; Novick AC; Williams BR
J Urol; 2009 Feb; 181(2):849-60. PubMed ID: 19095258
[TBL] [Abstract][Full Text] [Related]
15. Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.
Xiong Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2017 Apr; 8(15):25650-25659. PubMed ID: 27783999
[TBL] [Abstract][Full Text] [Related]
16. Expression of inflammatory lipopolysaccharide binding protein (LBP) predicts the progression of conventional renal cell carcinoma - a short report.
Kovacs G; Peterfi L; Farkas N; Javorhazy A; Pusztai C; Szanto A
Cell Oncol (Dordr); 2017 Dec; 40(6):651-656. PubMed ID: 28936621
[TBL] [Abstract][Full Text] [Related]
17. Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.
Fu Q; Chang Y; Zhou L; An H; Zhu Y; Xu L; Zhang W; Xu J
Oncotarget; 2016 Feb; 7(7):8413-21. PubMed ID: 26716905
[TBL] [Abstract][Full Text] [Related]
18. Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas.
Chen Y; Yusenko MV; Kovacs G
J Pathol; 2011 Jan; 223(1):46-53. PubMed ID: 20922711
[TBL] [Abstract][Full Text] [Related]
19. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
[TBL] [Abstract][Full Text] [Related]
20. Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma.
Feng G; Jiang F; Pan C; Pu C; Huang H; Li G
Urol Oncol; 2014 Jan; 32(1):44.e9-14. PubMed ID: 24054866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
